Cirius Therapeutics' Series A Round

Cirius Therapeutics raised a round of funding on April 10, 2017.

Cirius Therapeutics, formerly Octeta Therapeutics, a clinical-stage pharmaceutical company, is developing MSDC-0602K, an insulin sensitizer for the treatment of nonalcoholic steatohepatitis (NASH). MS…

Articles about Cirius Therapeutics' Series A Round: